010-58156160-822
CNLifetime Achievement Award of China Pharmaceutical Innovation
Winner(s)
Sang Guowei, Academician of Chinese Academy of Engineering, Chief Engineer of National Key Project on Innovation and Development of Major New Drugs
Innovative Drugs with Most Clinical Value
Winner(s)
Chemical Drug: Chidamide (Epidaza)-Shenzhen Chipscreen Biosciences, Ltd.
Biological Drug: Recombinant Human Prourokinase for Injection-Shanghai Tasly Pharmaceutical Co., Ltd.
Traditional Chinese Medicine: Ginkgolide Injection-Chengdu Baiyu Pharmaceutical Co., Ltd.
Generic Drugs with Most Clinical Value
Winner(s)
Entecavir API and Dispersible Tablets-Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Docetaxel Injection-Jiangsu Hengrui Medicine Co., Ltd.
Pemetrexed Disodium for Injection-Qilu Pharmaceutical Co., Ltd.
Most Innovative Pharmaceutical Enterprises
Winner(s)
Manufacturing:
LUYE Pharma Group Co., Ltd.
Simcere Pharmaceutical Group
R&D:
Innovent Biologics (Suzhou) Co., Ltd.
Traditional Chinese Medicine:
Taiji Group Co., Ltd.
Most Innovative Figures
Winner(s)
Most Innovative Figures of Pharmaceutical Innovative Enterprises:
Ding Lieming, Chairman of the Board&CEO, Betta Pharmaceutical Co., Ltd.
Xiao Wei, Chairman of the Board, Jiangsu Kanion Pharmaceutical Co., Ltd.
Most Innovative Figure of Drug R&D:
Su Weiguo, Chief Scientific Officer, Hutchison MediPharma Limited
Most Innovative Figure of Clinical R&D:
Cui Yimin, Director of Clinical Trial Center, Peking University First Hospital